Aikido pharma inc. (SPEX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets
Cash and cash equivalents

252

91

313

564

446

17

109

178

63

197

233

733

210

134

303

392

494

142

157

87

111

805

5,550

7,146

4,503

3,125

2,541

3,019

3,448

4,498

3,650

4,198

4,808

4,911

5,022

5,564

5,575

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

5,083

-

-

-

1,468

3,392

775

775

2,861

3,500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

16,141

857

938

817

1,256

2,700

3,409

4,634

5,574

3,998

4,735

2,920

-

6,025

6,968

5,671

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

165

181

52

106

165

188

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

0

209

146

0

167

320

0

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3

2

34

17

111

0

81

35

0

Prepaid research expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

209

211

297

464

Prepaid expenses and other assets

-

-

-

-

-

-

76

146

228

150

42

95

145

135

59

99

292

330

20

73

71

107

68

87

107

151

51

70

82

102

24

55

87

116

3

102

155

Assets of segment held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

104

-

-

-

289

-

-

-

Assets of segment held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

156

-

-

-

-

-

-

Total current assets

16,558

1,129

1,303

1,487

1,867

2,905

3,594

4,958

5,865

4,345

5,010

3,748

5,438

6,294

7,330

6,162

2,254

3,864

952

935

3,043

4,412

5,618

7,233

4,610

3,276

2,592

3,090

3,535

4,706

3,864

4,481

5,154

5,527

5,486

6,319

6,824

Property and equipment, net

-

-

-

-

-

1

1

2

2

3

4

4

5

6

6

7

7

5

3

3

4

4

4

-

-

0

0

2

7

24

42

59

76

85

108

122

154

Patent portfolios and patent rights, net

-

-

-

-

-

-

1,500

2,897

3,240

3,578

3,924

4,270

4,613

4,951

8,201

8,737

9,268

9,799

13,910

9,776

52,582

55,004

57,481

59,957

62,407

64,835

-

-

-

0

0

0

0

0

0

0

2

Investments

5,032

10,153

8,130

10,565

10,070

10,345

2,725

1,725

1,045

1,020

1,020

675

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,712

1,712

1,712

1,712

1,712

1,712

1,712

1,711

-

-

0

-

-

-

-

-

-

-

Patent portfolio, net of accumulated amortizationof $133,785 and $0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,967

-

-

-

-

-

-

-

-

-

-

Deposit

-

-

-

-

-

-

26

26

26

26

26

26

26

26

26

26

26

26

26

26

26

26

26

30

30

30

29

29

29

26

25

25

35

35

35

35

35

Assets of segment held for sale, non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

-

-

Total assets

21,590

11,282

9,433

12,052

11,937

13,251

7,846

9,608

10,178

8,972

9,984

8,723

10,082

11,277

15,563

14,932

11,555

13,694

14,891

12,452

57,367

61,158

64,841

68,932

68,759

69,853

9,302

3,122

3,572

4,756

3,932

4,565

5,266

5,655

5,630

6,477

7,017

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses

177

68

257

232

122

132

68

206

166

56

48

103

175

123

64

260

355

384

441

531

674

728

145

881

1,039

270

486

373

358

428

213

180

220

269

250

261

1,211

Accrued salaries and benefits

438

682

594

605

648

732

578

592

625

695

269

82

339

446

-

-

111

645

215

265

634

329

39

41

77

233

48

67

85

285

454

354

278

242

432

345

563

Warrant liabilities

-

-

1

8

135

82

262

357

634

822

961

2,028

824

702

-

-

1,417

2,959

1,759

-

-

0

-

-

-

48

39

76

215

3,126

-

-

-

916

-

-

-

Payable to DatChat

-

-

-

-

77

207

348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term deferred revenue

-

-

-

-

-

-

-

-

-

957

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term deferred revenue

-

-

-

-

-

-

0

0

0

-

1,000

1,073

1,145

1,216

-

-

290

290

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued salaries and benefits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

534

74

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

904

1,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,246

1,246

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

105

101

-

68

68

-

Accrued patent cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,000

-

-

-

0

-

-

-

-

-

-

-

Short-term lease liabilities

-

-

-

-

-

-

0

0

0

48

94

140

187

183

182

179

178

178

177

175

-

173

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Accrued patent costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,000

-

-

-

-

-

-

-

-

-

-

Short-term lease liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

174

-

-

-

-

-

2

5

10

18

80

-

-

380

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

8

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

615

750

852

845

982

1,153

1,256

1,155

1,425

2,578

2,372

3,426

2,670

2,670

2,930

3,687

2,351

4,456

2,592

971

1,482

1,230

185

923

1,124

1,503

1,537

446

453

731

748

639

600

892

750

676

1,945

Long-term deferred revenue

-

-

-

-

-

-

-

-

-

2,288

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred revenue

-

-

-

-

-

-

0

0

0

-

2,530

2,771

3,009

3,245

3,529

3,843

188

259

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term lease liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

44

-

-

184

229

274

319

363

407

-

-

-

0

45

44

45

45

44

40

39

47

56

64

80

Total liabilities

615

750

852

845

982

1,153

1,256

1,155

1,425

4,866

4,902

6,197

5,679

5,959

-

-

2,723

4,944

2,866

1,290

1,845

1,637

-

-

-

1,551

1,622

567

714

3,902

793

679

639

1,856

807

741

2,576

Series I redeemable convertible preferred stock, $0.0001 par value; no shares issued and outstanding at March 31, 2017 and December 31, 2016; liquidation preference of $167 per share

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

5,000

5,000

5,935

5,935

5,935

5,935

20,000

20,000

-

-

-

0

-

-

-

-

-

-

-

Long-term lease liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

92

138

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,551

7,668

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series I redeemable convertible preferred stock, $0.0001 par value; no shares issued and outstanding at September 30, 2016 and December 31, 2015; liquidation preference of $167 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

0

0

-

0

-

-

0

0

-

-

0

0

0

0

0

-

0

0

0

Stockholders' equity
Preferred Stock

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

Series A: No shares issued and outstanding, at September 30, 2013 andDecember 31, 2012; liquidation preference $1,000 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series B: 1 share issued and outstanding, at September 30, 2013 and December 31, 2012; liquidation preference $1,000 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series C: 1 and no shares issued and outstanding, at September 30, 2013 and December 31, 2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series D: 1,379,685 and no shares issued and outstanding, at September 30, 2013 andDecember 31, 2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series E: No shares issued and outstanding, at September 30, 2013 and December 31, 2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series F: No shares issued and outstanding, at September 30, 2013 andDecember 31, 2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Series B: 1 Share issued and outstanding at June 30, 2013 and December 31,2012; liquidation preference $1,000 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Series C: 158,944 shares issued and outstanding at June 30, 2013 and none issued and outstanding at December 31,2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Series E: 100,000 shares issued and outstanding at June 30, 2013 and none issued and outstanding at December 31, 2012; liquidation preference $0.0001 per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Common stock, $0.0001 par value, 100,000,000 shares authorized; 20,857,912 and 4,825,552 shares issued at March 31, 2020 and December 31, 2019, respectively; 20,857,909 and 4,825,549 shares outstanding at March 31, 2020 and December 31, 2019, respectively

2

-

-

-

-

-

1

1

1

-

0

0

0

0

0

0

0

0

3

3

3

0

3

3

1

0

0

0

0

0

0

41

41

0

25

25

0

Additional paid-in-capital

173,836

155,062

154,084

153,347

152,451

152,445

152,438

152,410

152,312

149,425

149,415

147,318

147,335

147,331

-

-

144,418

144,287

138,214

137,769

137,742

137,658

136,933

135,142

109,137

102,043

57,239

42,834

42,330

36,630

43,420

43,359

43,353

35,717

41,109

41,109

38,590

Additional paid-in-capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

147,122

144,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Treasury stock, at cost, 3 shares at March 31, 2020 and December 31, 2019

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

264

465

464

464

464

465

464

464

464

464

464

464

464

Accumulated deficit

-152,599

-144,266

-145,239

-141,876

-141,232

-140,083

-145,585

-143,694

-143,296

-145,055

-144,069

-144,528

-142,668

-141,749

-137,846

-137,400

-135,322

-135,273

-130,928

-131,346

-87,894

-83,808

-77,951

-72,807

-61,239

-53,276

-49,094

-39,814

-39,007

-35,311

-39,816

-39,050

-38,302

-31,454

-35,847

-34,934

-33,685

Total stockholders' equity

20,975

10,532

8,581

11,207

10,955

12,098

6,590

8,453

8,753

4,106

5,082

2,526

4,403

5,318

9,012

7,264

8,832

8,750

7,025

6,162

49,587

53,586

58,721

62,074

47,635

48,302

7,679

2,555

2,857

854

3,139

3,886

4,627

3,798

4,823

-

4,440

Total stockholders' equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,736

-

Total liabilities and stockholders' equity

21,590

11,282

9,433

12,052

11,937

13,251

7,846

9,608

10,178

8,972

9,984

8,723

10,082

11,277

15,563

14,932

11,555

13,694

14,891

12,452

57,367

61,158

64,841

68,932

68,759

69,853

9,302

3,122

3,572

4,756

3,932

4,565

5,266

5,655

5,630

6,477

7,017